
The KUR Difference
How can pharmaceuticals, biotech, or CROs mitigate
the impact, the slow enrollment and start-up delays
upon their clinical trials?
industry trends continue to demonstrate that slow
enrolment is the top issue plaguing clinical research.
80% of clinical trials experience delayed enrollment
48% never achieve the initial enrollment goal
Why KUR Research?
With over 10 years of experience, KUR offers
innovative solutions to address challenges in
clinical research.
Their team delivers high-quality trials across all
phases, focusing on drug, device, and diagnostic
development, beyond traditional clinical sites.
-
Our Network
Our network is designed to be effective, efficient and fosters Faster Patient Enrollment. Our investigators effectively attract and retain patients in clinical trials by building patient relationships, ensuring their engagement & compliance throughout the trial. Our Investigative Site Network is augmented by KUR trained and experienced site-level research staff who are , focused on patient recruitment, protocol execution, compliance, and data quality.
-
Patient Management
Our proprietary database of patient information allows us to properly store patient data as well as efficiently search our database by age, gender, risk factors, and various inclusion/exclusion criteria. By filtering our database, we can provide sponsors with obtainable enrollment milestones and gear our clinical trials toward the needs of our patients.
-
Quality Assurance and Data management
Our dedicated 24 x 7 quality assurance team is consistently monitoring data to ensure data quality and integrity. Kur quality professionals remotely evaluate data collection, regulatory documents, review sponsor feedback from recent monitoring visits, and maintain equipment calibration documentation. We Provide Sponsors and CROs access to an eSource system for QA and monitoring activities the data is ready for source verification and external monitoring by the CRA within 24 hours of the subject visit.
-
Central Clinical Trials Management System
We are 95% digital and all clinical trial data is documented through our web-based Clinical Trial Management System (CTMS) to ensure quality, accuracy, and contemporaneity. With the rising need for remote capabilities within the research industry, our CTMS allows for seamless remote monitoring and real-time quality assurance auditing. By utilizing a CTMS, we can accurately track budgets, costs, and invoices to ensure an accurate financial outcome for each trial.
-
Central Marketing
KUR Research works closely with sponsors to ensure enrollment goals are maintained throughout the duration of the study. One tool utilized to assist with enrollment hurdles is marketing and advertisement. By utilizing Institutional Review Board (IRB) approved marketing materials, we reach potential subjects from a variety of digital, print, and social media sources.
-
One Company, One Solution
One of the many benefits of working with KUR Research is the streamlined process we utilize for study start-up. Sponsors can expect to execute the CTA and budget for all KUR sites through one department, and all regulatory start up documents will be handled and maintained by a KUR regulatory representative.
We understand that the start-up process is only the beginning of a long-term relationship with our sponsors, and KUR Research ensures an excellent experience from the start.
1. Study Start-up Process
Our Study Startup Process is based on the needs of the Sponsor. We are able to go from Site Selection to First Subject Enrolled in (as fast as) 10 days
- Scheduling
- SIVs Source Creation
- Source Validation
- Budget Negotiations
- Regulatory
- Contract Negotiations
2. Our Centralized Solutions:
Our Centralized Solutions are Designed to promote Quality and Consistency across Sites and Protocols by centralizing relevant processes to our corporate office
- CDA Execution
- Inform Consent Process
- AE/SAE Identification and Processing
- FQ Completion & Submission
- Staff Training
- Investigational Product & Supply Management
- Site Identification Feasibility
- Common SOP
- Temperature Monitoring
- Clinical Protocol Evaluation
- IT & CTMS Infrastructure
- Monitoring and Audit Support
- Protocol Management Assignment
- Clinical Site Biz. Dev. & Marketing
- Communication with CRO & Sponsors
- Budget Negotiations
- Quality Assurance / Quality Control
- Study Close Out
- Contract Negotiations
- Data Management / EDC Entry
- Patient Data and Site File Archiving
- Regulatory Activities
- Query Resolution
- Full AR/AP/Billing/Invoicing Cycle
- IRB/IEC Submission
- Subject Engagement & Recruitment
Acute & Chronic Conditions
Phases II to IV trials Adults and Pediatrics subjects
- Allergy/Immunology
- Cardiology
- Consumer Health
- Decentralized
- Dermatology
- Diagnostics
- Endocrinology/Metabolic Disorders
- Family Practice
- Allergy/Immunology
- Cardiology
- Consumer Health
- Decentralized
- Dermatology
- Diagnostics
Vaccines
Test new candidate vaccines
- Anthrax
- Avian Influenza
- difficile (C-diff)
- Celiac Disease
- Chikungunya
- Dengue fever
- Diphtheria
- Ebola
- Encephalitis
Sample & Diagnostic Trials
Collect High-quality biological specimens
- Via Specific sponsor protocol
- Via its sister company, Vexillum
Experts at the complexity, speed, quality and volume of subjects needed to successfully conduct Diagnostic Clinical Trials.
Specialty Population
- Geriatrics
- Women’s Health
- Pediatrics: Pediatric clinical trials are essential to develop age-specific therapies and intervention to provide the best medical treatment available. KUR Research has sites experienced with the specific ethical and clinical concerns of conducting trials within this special population, from newborn through adolescents.
Age Distribution

Sex Distribution

Ethnicity Distribution

Race Distribution
